“…Inadvertent intrathecal administration of vincristine: Time to finally abolish the syringe Peter J Gilbar 1,2 In this edition of the journal, Bruhwiler and Schwappach present results of a survey investigating the implementation of safety measures for vincristine and intrathecal (IT) chemotherapies in Switzerland. 1 Of 21 hospitals who manufactured both parenteral chemotherapy and IT chemotherapy, 16 (76%) still prepared vincristine in syringes mainly in small volumes. The most prevalent safety measures in use were specific labelling for vincristine and special delivery systems for IT medications.…”